Global Coronary Artery Bypass Graft (CABG) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Coronary Artery Bypass Graft (CABG) Market Research Report 2024
Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.
According to MRAResearch’s new survey, global Coronary Artery Bypass Graft (CABG) market is projected to reach US$ 164.3 million in 2033, increasing from US$ 128.5 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Coronary Artery Bypass Graft (CABG) market research.
Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.
In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Coronary Artery Bypass Graft (CABG) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Medtronic
TERUMO
Guidant
MAQUET
Vitalitec
Novadaq Technologies
KARL STORZ
Edwards Lifesciences
Genesee Biomedical
Sorin
Segment by Type
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
Other Grafts
Medical Application
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Coronary Artery Bypass Graft (CABG) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Coronary Artery Bypass Graft (CABG) market is projected to reach US$ 164.3 million in 2033, increasing from US$ 128.5 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Coronary Artery Bypass Graft (CABG) market research.
Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.
In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Coronary Artery Bypass Graft (CABG) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
TERUMO
Guidant
MAQUET
Vitalitec
Novadaq Technologies
KARL STORZ
Edwards Lifesciences
Genesee Biomedical
Sorin
Segment by Type
Saphenous Vein Grafts
Internal Thoracic Artery Grafts
Other Grafts
Segment by Application
Medical Application
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Coronary Artery Bypass Graft (CABG) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source